日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Pig Retinoic acid receptor RXR-gamma (RXRG) CSB-YP607765PI
CSB-EP607765PI
CSB-BP607765PI
CSB-MP607765PI
CSB-EP607765PI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Horsepox virus Kelch repeat and BTB domain-containing protein 1 (KBTB1), partial CSB-YP607766HAAK
CSB-EP607766HAAK
CSB-BP607766HAAK
CSB-MP607766HAAK
CSB-EP607766HAAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Tityus trivittatus Potassium channel toxin Ttr-beta-KTx CSB-YP607767TEW
CSB-EP607767TEW
CSB-BP607767TEW
CSB-MP607767TEW
CSB-EP607767TEW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rotavirus Outer capsid glycoprotein VP7, partial CSB-YP607768RIR
CSB-EP607768RIR
CSB-BP607768RIR
CSB-MP607768RIR
CSB-EP607768RIR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ustilago maydis Cytochrome b (COB), partial CSB-YP607769UBS
CSB-EP607769UBS
CSB-BP607769UBS
CSB-MP607769UBS
CSB-EP607769UBS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ustilago maydis Probable intron-encoded endonuclease aI5 (aI5), partial CSB-YP607770UBS
CSB-EP607770UBS
CSB-BP607770UBS
CSB-MP607770UBS
CSB-EP607770UBS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ustilago maydis NADH-ubiquinone oxidoreductase chain 2 (ND2), partial CSB-YP607771UBS
CSB-EP607771UBS
CSB-BP607771UBS
CSB-MP607771UBS
CSB-EP607771UBS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Influenza A virus Protein PB1-F2 (PB1-F2) CSB-YP607772IER
CSB-EP607772IER
CSB-BP607772IER
CSB-MP607772IER
CSB-EP607772IER-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Influenza A virus Hemagglutinin (HA), partial CSB-YP607773IER
CSB-BP607773IER
CSB-MP607773IER
CSB-EP607773IER-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. ATP synthase subunit a (atpB), partial CSB-YP607774SAAN1
CSB-EP607774SAAN1
CSB-BP607774SAAN1
CSB-MP607774SAAN1
CSB-EP607774SAAN1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Bifunctional protein GlmU (glmU) CSB-YP607775SAAN
CSB-EP607775SAAN
CSB-BP607775SAAN
CSB-MP607775SAAN
CSB-EP607775SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Protoheme IX farnesyltransferase 2 (cyoE2), partial CSB-YP607776SAAN
CSB-EP607776SAAN
CSB-BP607776SAAN
CSB-MP607776SAAN
CSB-EP607776SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Acetylglutamate kinase (argB) CSB-YP607777SAAN
CSB-EP607777SAAN
CSB-BP607777SAAN
CSB-MP607777SAAN
CSB-EP607777SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Cell division protein ZapB (zapB) CSB-YP607778SAAN
CSB-EP607778SAAN
CSB-BP607778SAAN
CSB-MP607778SAAN
CSB-EP607778SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. 50S ribosomal protein L28 (rpmB) CSB-YP607779SAAN
CSB-EP607779SAAN
CSB-BP607779SAAN
CSB-MP607779SAAN
CSB-EP607779SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Phospho-N-acetylmuramoyl-pentapeptide-transferase (mraY), partial CSB-YP607780SAAN
CSB-EP607780SAAN
CSB-BP607780SAAN
CSB-MP607780SAAN
CSB-EP607780SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Ubiquinone/menaquinone biosynthesis methyltransferase ubiE (ubiE) CSB-YP607781SAAN
CSB-EP607781SAAN
CSB-BP607781SAAN
CSB-MP607781SAAN
CSB-EP607781SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Phosphoribosylaminoimidazole-succinocarboxamide synthase (purC) CSB-YP607782SAAN
CSB-EP607782SAAN
CSB-BP607782SAAN
CSB-MP607782SAAN
CSB-EP607782SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Glycine dehydrogenase [decarboxylating] (gcvP), partial CSB-YP607783SAAN
CSB-EP607783SAAN
CSB-BP607783SAAN
CSB-MP607783SAAN
CSB-EP607783SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella sp. Alanine racemase (alr) CSB-YP607784SAAN
CSB-EP607784SAAN
CSB-BP607784SAAN
CSB-MP607784SAAN
CSB-EP607784SAAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×